Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples